National Institutes of Health Clinical Center Hematology and Medical Oncology

Topics

• CAR-T cell therapy research 619
• Hematopoietic Stem Cell Transplantation 572
• Immunotherapy and Immune Responses 523
• Acute Myeloid Leukemia Research 442
• Hemoglobinopathies and Related Disorders 386
• Cancer Immunotherapy and Biomarkers 372
• Lymphoma Diagnosis and Treatment 308
• Chronic Lymphocytic Leukemia Research 275
• Multiple Myeloma Research and Treatments 258
• Prostate Cancer Treatment and Research 219
• Immune Cell Function and Interaction 210
• Virus-based gene therapy research 201

Most cited

1. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 1,863 citations · Monalisa Ghosh

2. Long-term outcomes following CAR T cell therapy: what we know so far.

   Nature reviews. Clinical oncology · 2023 · 1,155 citations · Kathryn Cappell, James Kochenderfer

3. Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

   The New England journal of medicine · 2021 · 1,483 citations · Andrea Apolo

4. Cancer treatments: Past, present, and future.

   Cancer genetics · 2024 · 490 citations · Anish Thomas

5. Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.

   The New England journal of medicine · 2023 · 739 citations · Yuanbin Chen

6. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.

   The New England journal of medicine · 2023 · 550 citations · Najla El Jurdi